ask="N/A"
ask_size="N/A"
average_daily_volume="11095"
bid="N/A"
bid_size="N/A"
book_value="2.2200"
change="+0.4036"
change_from_200_day_moving_average="0.0128"
change_from_50_day_moving_average="0.5637"
change_from_52_week_high="-1.8164"
change_From_52_week_low="1.2736"
change_in_percent="+11.5977%"
close="3.8836"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.7370"
ebitda="-19.08M"
eps_estimate_current_year="-1.8000"
eps_estimate_next_quarter="-0.4100"
eps_estimate_next_year="-1.7000"
ex_dividend_date="N/A"
float_shares="1799000"
high="4.0000"
high_52_weeks="5.7000"
last_trade_date="3/10/2017"
last_trade_price="3.8836"
last_trade_size="500"
last_trade_time="3:52pm"
low="3.4000"
low_52_weeks="2.6100"
market_capitalization="45.64M"
moving_average_200_day="3.8708"
moving_average_50_day="3.3199"
name="Nexvet Biopharma plc - Ordinary"
notes="N/A"
one_year_target_price="8.0000"
open="3.4390"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+0.3304%"
percent_change_from_50_day_moving_average="+16.9780%"
percent_change_from_52_week_high="-31.8667%"
percent_change_from_52_week_low="+48.7969%"
previous_close="3.4800"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.5676"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11752000"
short_ratio="8.8600"
stock_exchange="NGM"
symbol="NVET"
volume="81618"
weeks_range_52="2.6100 - 5.7000"
